Delivery Order SPE2DB20D9331-SPE2DB23FL0K7

Award Date 1/4/23
Potential Completion Date 1/5/23
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order (SPE2DB22D9239|SPE2DB24FDK94) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,960.20 order is for CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS...
This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $1,428.00, is for the supply of CATHFLO ACTIVASE 2 MG VIALS to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price delivery order with no set-aside designation. It is part of a larger indefinite delivery contract (IDC) held by...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $1,071.00 for the supply of 4564878329 CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program....
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $4,522.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of 4566120507 CATHFLO ACTIVASE 2 MG VIALS, a specialized pharmaceutical product, with a period of performance through October 17, 2024. This contract award is part of a larger, single-award Indefinite Delivery Contract (IDC) valued...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,036.99, is for the delivery of 4567515199 ACTIVASE 50 MG VIALS. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,768.16, covers the delivery of Cathflo Activase 2 mg vials to support the medical supply needs of military healthcare facilities. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 held by DMS Pharmaceutical Group with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $12,732.92, is for the delivery of ACTIVASE 50 MG VIALS medical supplies. The award is part of a larger single-award indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,570.00 firm fixed-price delivery order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a period of performance through August 29, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Activase 100 mg vials. The order, valued at $14,015.45, is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a wide range of pharmaceutical items to support the medical supply needs of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $6,253.96, is for the delivery of Activase 50 mg vials. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB23FL0K7
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,415.92, is to provide 4559553989 - CATHFLO ACTIVASE 2 MG VIALS to the DLA. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities worldwide. The contract has no set-aside designation.

Generated 1/9/25, 9:27 AM